Literature DB >> 12874291

Cell surface-bound heat shock protein 70 (Hsp70) mediates perforin-independent apoptosis by specific binding and uptake of granzyme B.

Catharina Gross1, Walter Koelch, Antonio DeMaio, Nelson Arispe, Gabriele Multhoff.   

Abstract

Cell surface-bound heat shock protein 70 (Hsp70) renders tumor cells more sensitive to the cytolytic attack mediated by natural killer (NK) cells. A 14-amino acid Hsp70 sequence, termed TKD (TKDNNLLGRFELSG, aa450-463) could be identified as the extracellular localized recognition site for NK cells. Here, we show by affinity chromatography that both, full-length Hsp70-protein and Hsp70-peptide TKD, specifically bind a 32-kDa protein derived from NK cell lysates. The serine protease granzyme B was uncovered as the 32-kDa Hsp70-interacting protein using matrix-assisted laser desorption ionization time-of-flight mass peptide fingerprinting. Incubation of tumor cells with increasing concentrations of perforin-free, isolated granzyme B shows specific binding and uptake in a dose-dependent manner and results in initiation of apoptosis selectively in tumor cells presenting Hsp70 on the cell surface. Remarkably, Hsp70 cation channel activity was also determined selectively in purified phospholipid membranes of Hsp70 membrane-positive but not in membrane-negative tumor cells. The physiological role of our findings was demonstrated in primary NK cells showing elevated cytoplasmic granzyme B levels following contact with TKD. Furthermore, an increased lytic activity of Hsp70 membrane-positive tumor cells could be associated with granzyme B release by NK cells. Taken together we propose a novel perforin-independent, granzyme B-mediated apoptosis pathway for Hsp70 membrane-positive tumor cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12874291     DOI: 10.1074/jbc.M302644200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  55 in total

1.  Dendritic cell activation and maturation induced by recombinant calreticulin fragment 39-272.

Authors:  Yue Li; Xiaoli Zeng; Lijuan He; Hui Yuan
Journal:  Int J Clin Exp Med       Date:  2015-05-15

Review 2.  The human HSP70 family of chaperones: where do we stand?

Authors:  Jürgen Radons
Journal:  Cell Stress Chaperones       Date:  2016-02-10       Impact factor: 3.667

Review 3.  Mechanisms of HSP72 release.

Authors:  Alexzander Asea
Journal:  J Biosci       Date:  2007-04       Impact factor: 1.826

Review 4.  Death by a thousand cuts: granzyme pathways of programmed cell death.

Authors:  Dipanjan Chowdhury; Judy Lieberman
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

Review 5.  Chaperokine-induced signal transduction pathways.

Authors:  Alexzander Asea
Journal:  Exerc Immunol Rev       Date:  2003       Impact factor: 6.308

6.  Cationic sites on granzyme B contribute to cytotoxicity by promoting its uptake into target cells.

Authors:  Catherina H Bird; Jiuru Sun; Kheng Ung; Diana Karambalis; James C Whisstock; Joseph A Trapani; Phillip I Bird
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

7.  Perforin and granzymes work in synergy to mediate cholangiocyte injury in experimental biliary atresia.

Authors:  Pranavkumar Shivakumar; Reena Mourya; Jorge A Bezerra
Journal:  J Hepatol       Date:  2013-10-02       Impact factor: 25.083

8.  Granzyme B produced by human plasmacytoid dendritic cells suppresses T-cell expansion.

Authors:  Bernd Jahrsdörfer; Angelika Vollmer; Sue E Blackwell; Julia Maier; Kai Sontheimer; Thamara Beyer; Birgit Mandel; Oleg Lunov; Kyrylo Tron; G Ulrich Nienhaus; Thomas Simmet; Klaus-Michael Debatin; George J Weiner; Dorit Fabricius
Journal:  Blood       Date:  2009-12-03       Impact factor: 22.113

Review 9.  The therapeutic implications of clinically applied modifiers of heat shock protein 70 (Hsp70) expression by tumor cells.

Authors:  Mathias Gehrmann; Jürgen Radons; Michael Molls; Gabriele Multhoff
Journal:  Cell Stress Chaperones       Date:  2008-02-05       Impact factor: 3.667

10.  Anti-tumor activity of patient-derived NK cells after cell-based immunotherapy--a case report.

Authors:  Valeria Milani; Stefan Stangl; Rolf Issels; Mathias Gehrmann; Beate Wagner; Kathrin Hube; Doris Mayr; Wolfgang Hiddemann; Michael Molls; Gabriele Multhoff
Journal:  J Transl Med       Date:  2009-06-23       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.